These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33838929)

  • 21. Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients.
    Kaplan AP; Ghebrehiwet B
    J Allergy Clin Immunol; 2021 Feb; 147(2):507-509. PubMed ID: 33129885
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.
    Lee JW; Lee IH; Sato T; Kong SW; Iimura T
    Dev Growth Differ; 2021 Apr; 63(3):219-227. PubMed ID: 33595856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.
    Hecker LA; Edwards AO; Ryu E; Tosakulwong N; Baratz KH; Brown WL; Charbel Issa P; Scholl HP; Pollok-Kopp B; Schmid-Kubista KE; Bailey KR; Oppermann M
    Hum Mol Genet; 2010 Jan; 19(1):209-15. PubMed ID: 19825847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From gene to disease; the haemolytic uraemic syndrome can be caused by mutations in regulating factors of the alternative route of the complement system].
    Geelen JM; Klasen IS; van den Heuvel LP; Monnens LA
    Ned Tijdschr Geneeskd; 2007 Jan; 151(3):185-8. PubMed ID: 17288344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative pathway diagnostics.
    Thurman JM; Fremeaux-Bacchi V
    Immunol Rev; 2023 Jan; 313(1):225-238. PubMed ID: 36305168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
    Kasela S; Ortega VE; Martorella M; Garudadri S; Nguyen J; Ampleford E; Pasanen A; Nerella S; Buschur KL; Barjaktarevic IZ; Barr RG; Bleecker ER; Bowler RP; Comellas AP; Cooper CB; Couper DJ; Criner GJ; Curtis JL; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Krishnan JA; Martinez FJ; McDonald MN; Meyers DA; Paine R; Peters SP; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Levy BD; Li X; Moore WC; Wenzel SE; Zein J; ; ; Langelier C; Woodruff PG; Lappalainen T; Christenson SA
    Genome Med; 2021 Apr; 13(1):66. PubMed ID: 33883027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients.
    Lage SL; Rocco JM; Laidlaw E; Rupert A; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Lisco A; Manion M; Sereti I
    Front Immunol; 2022; 13():815833. PubMed ID: 35250994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host transcriptional response to SARS-CoV-2 infection in COVID-19 patients.
    Singh NK; Srivastava S; Zaveri L; Bingi TC; Mesipogu R; Kumar V S; Gaur N; Hajirnis N; Machha P; Shambhavi S; Khan S; Soujanya M; Nagabandi T; Mishra RK; Tallapaka KB; Sowpati DT
    Clin Transl Med; 2021 Sep; 11(9):e534. PubMed ID: 34586723
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases.
    Rodríguez de Córdoba S
    Immunol Rev; 2023 Jan; 313(1):71-90. PubMed ID: 36089777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain.
    Strohmeyer R; Shen Y; Rogers J
    Brain Res Mol Brain Res; 2000 Sep; 81(1-2):7-18. PubMed ID: 11000474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The authors reply:
    Servais A; Noel LH; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2013 Feb; 83(2):332-3. PubMed ID: 23364592
    [No Abstract]   [Full Text] [Related]  

  • 32. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
    Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ
    J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.
    Gupta A; Gupta GS
    Mol Cell Biochem; 2021 Aug; 476(8):2917-2942. PubMed ID: 33745077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The story of complement factor I.
    Lachmann PJ
    Immunobiology; 2019 Jul; 224(4):511-517. PubMed ID: 31109748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
    Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A; Guider W; Stewart C; Rosenzweig SD; Wang H; Jean S; Peeples M; King T; Hunt WG; Honegger JR; Ramilo O; Mustillo PJ; Mejias A; Ardura MI; Shimamura M
    J Allergy Clin Immunol; 2021 Feb; 147(2):532-544.e1. PubMed ID: 33007327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response to COVID-19 infection: a double-edged sword.
    Saad N; Moussa S
    Immunol Med; 2021 Sep; 44(3):187-196. PubMed ID: 33444511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.